Mein Warenkorb

CD2

CD2 Molekülinformation

Englischer NameT-cell surface antigen CD2Anzahl der inverkehr gebrachten Arzneimittel0
Anzahl der klinischen Arzneimittel3Target-AliasT11,T-Cell Surface Antigen CD2,LFA-2,CD2 Antigens,CD2,LFA-3 Receptor,CD2 Molecule,Rosette Receptor,SRBC,CD2 Antigen,CD2 Antigen (P50), Sheep Red Blood Cell Receptor,T-Cell Surface Antigen T11/Leu-5,Lymphocyte-Function Antigen-2,Erythrocyte Receptor
Höchste Forschungs- und EntwicklungsphasePhase 2 Clinical
Englischer NameT-cell surface antigen CD2
Target-AliasT11,T-Cell Surface Antigen CD2,LFA-2,CD2 Antigens,CD2,LFA-3 Receptor,CD2 Molecule,Rosette Receptor,SRBC,CD2 Antigen,CD2 Antigen (P50), Sheep Red Blood Cell Receptor,T-Cell Surface Antigen T11/Leu-5,Lymphocyte-Function Antigen-2,Erythrocyte Receptor
Anzahl der inverkehr gebrachten Arzneimittel0
Anzahl der klinischen Arzneimittel3
Höchste Forschungs- und EntwicklungsphasePhase 2 Clinical

CD2 Produktliste

  • Attribut

    Protein (6)Antibody (6)

  • Produktbibliothek

    Online (12)

  • Spezies

    Human (5)Cynomolgus (2)Rabbit (1)Mouse (4)

  • Etikett

    His Tag (3)Fc Tag (1)His Tag & Avi Tag (2)- (6)

  • Marker

    Unconjugated (7)Biotin-labeled (2)PE Labeled (1)APC Labeled (2)

CD2 Molekülhintergrund

T-cell surface antigen CD2 is also known as Erythrocyte receptor, LFA-2, LFA-3 receptor, Rosette receptor, T-cell surface antigen T11/Leu-5 and SRBC, is a single-pass type I membrane protein found on the surface of T cells and natural killer (NK) cells. CD2 is a member of the immunoglobulin superfamily. CD2 / SRBC contains 1 Ig-like C2-type (immunoglobulin-like) domain and 1 Ig-like V-type (immunoglobulin-like) domain. CD2 / SRBC interacts with other adhesion molecules, such as lymphocyte function-associated antigen-3 (LFA-3 / CD58) in humans, or CD48 in rodents, which are expressed on the surfaces of other cells. In addition to its adhesive properties, CD2 also acts as a co-stimulatory molecule on T and NK cells. CD2 is a specific marker for T cells and NK cells, and can therefore be used in immunohistochemistry to identify the presence of such cells in tissue sections.

CD2 Molekülalias

CD2,SRBC,LFA-2,T11

Klinische Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaIndikationenKlinische Studie
SiplizumabMEDI-507; TCD-601Phase 2 ClinicalCatholic University Of Louvain, Itb-Med LlcAmyotrophic Lateral Sclerosis; Anemia, Sickle Cell; Cholangitis, Sclerosing; Diabetes Mellitus, Type 1; End Stage Liver Disease; Graft vs Host Disease; Hepatitis, Autoimmune; Hidradenitis Suppurativa; Kidney Diseases; Kidney Failure, Chronic; Leukemia; Liver Cirrhosis; Liver Diseases; Lymphoma; Lymphoma, Extranodal NK-T-Cell; Lymphoma, T-Cell; Multiple Myeloma; Myelodysplastic Syndromes; Neoplasms; Plaque psoriasis; Psoriasis; Rejection of renal transplantation; Rejection of liver transplantation; Renal Insufficiency
Details
SBT-11-5301SBT115301Phase 1 ClinicalSonoma Biotherapeutics IncAutoimmune Diseases
Details
PIT-565PIT-565Phase 1 ClinicalNovartis Pharma AgArthritis, Rheumatoid; Lupus Erythematosus, Systemic; Lymphoma, B-Cell; Neoplasms; Nephrosis; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
Details
  • Molekülinformation
  • Produktliste
  • Klinische Arzneimittelinformation
Kontaktieren Sie uns